Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2013 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DHI Group Inc | 4 | Q3 2022 | 7.9% |
Tetra Technologies Inc | 4 | Q3 2022 | 6.5% |
Harrow Health Inc | 4 | Q3 2022 | 8.4% |
TTEC Holdings Inc | 4 | Q3 2022 | 5.9% |
Clarus Corp | 4 | Q3 2022 | 5.9% |
Apyx Medical Corp | 4 | Q3 2022 | 6.5% |
InfuSystem Holdings Inc | 4 | Q3 2022 | 5.1% |
PAR Technology Corp | 4 | Q3 2022 | 4.9% |
Cantaloupe Inc | 4 | Q3 2022 | 5.2% |
Marcus Corp | 4 | Q3 2022 | 4.4% |
View Invenire Partners, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2023-03-31 |
SC 13G | 2023-01-23 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
D/A | 2019-03-12 |
D | 2018-01-02 |
View Invenire Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.